Prolonged decrease in vanilmandelic (3-Methoxy-4-hydroxymandelic) acid excretion by man during and after nialamide treatment.
D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000378:metabolism*; D008875:Middle Aged; D009526:Nialamide / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D014556:Urine
D008333:Mandelic Acids; D009526:Nialamide